Hemochromatosis type 1
MONDO:0021001Hemochromatosis type 1 (classic) is the most common form of hereditary hemochromatosis (HH), a group of diseases characterized by excessive tissue iron deposition. Due to its incidence (1/200-1/1000), it is not considered as a rare disease, unlike the other subforms of the disease
Also known as: C282Y/C282Y hemochromatosis, HFE-associated hereditary hemochromatosis, HFE-related hemochromatosis, HFE1, classic hemochromatosis, hemochromatosis, hemochromatosis type 1, hemochromatosis, type 1
4 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New pill could ease iron overload for thousands with genetic disorder
Disease control Recruiting nowThis phase 2 trial tests an experimental drug called vamifeport in 84 adults with HFE-related hereditary hemochromatosis, a genetic condition causing iron buildup. The drug aims to reduce liver iron levels, potentially offering an alternative to regular blood removal. Participant…
Phase: PHASE2 • Sponsor: CSL Behring • Aim: Disease control
Last updated Aug 18, 2026 04:00 UTC
-
NIH launches major study to unlock secrets of rare bone diseases
Knowledge-focused Recruiting nowThis study aims to collect information and bone samples from up to 1,000 people with bone or mineral disorders, such as tumor-induced osteomalacia or familial tumoral calcinosis. Participants receive standard medical evaluations and may provide bone tissue from surgery or a biops…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Aug 18, 2026 04:00 UTC